Nath Bio-Genes (India) Limited (BOM:537291)

Market Cap	2.69B
Revenue (ttm)	4.17B
Net Income (ttm)	441.66M
Shares Out	n/a
EPS (ttm)	23.27
PE Ratio	6.08
Forward PE	n/a
Dividend	2.00 (1.33%)
Ex-Dividend Date	Aug 14, 2025

Volume	6,972
Average Volume	2,181
Open	152.55
Previous Close	151.00
Day's Range	144.55 - 152.70
52-Week Range	141.10 - 238.00
Beta	n/a
RSI	25.72
Earnings Date	Feb 11, 2026

About Nath Bio-Genes (India)

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprising cabbage, chilli, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, sweet pepper, green peas,...

• Industry: Agricultural Production Crops
• Founded: 1979
• Employees: 451
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 537291

Financial Performance

In 2024, Nath Bio-Genes (India)'s revenue was 3.65 billion, an increase of 9.70% compared to the previous year's 3.33 billion. Earnings were 386.00 million, a decrease of -2.57%.